Organovo Holdings, Inc.
ONVO
Κατάταξη σε μετοχές
#36003
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Τιμή μετοχής
$2.00
Τελευταίος συγχρονισμός: 2025-05-19
Κεφαλαιοποίηση
$2.93M
Αλλαγή (1 ημέρα)
-3.38%
Αλλαγή (1 έτος)
656.14%
Χώρα
US
Εμπόριο Organovo Holdings, Inc. (ONVO)
Κατηγορία
Healthcare
Ιστορικό τιμής μετοχής για την Organovo Holdings, Inc. (ONVO)
Υψηλότερη τιμή κλεισίματος: $5.13 στις 2025-03-01
Χαμηλότερη τιμή κλεισίματος: $131.45 στις 2014-11-01
Χαμηλότερη τιμή κλεισίματος: $131.45 στις 2014-11-01
Ιστορικό τιμής μετοχής της Organovo Holdings, Inc. από 2014 έως 2026
Ετήσια απόδοση τιμής μετοχής
| Έτος | Απόδοση |
|---|---|
| 2025 | 6.61% |
| 2024 | -65.68% |
| 2023 | -24.35% |
| 2022 | -61.52% |
| 2021 | -70.29% |
| 2020 | -31.30% |
| 2019 | -29.19% |
| 2018 | 153.68% |
| 2014 | 0.00% |
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Τιμή μετοχής | Μεταβολή 1Έτ% | Χώρα |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.70 | 7.84% |
CH
|
